Trials / Completed
CompletedNCT00781560
Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal
A Cross-sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,575 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to survey the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists; To survey the control rate of the patients with dyslipidemia in "real world"; and to evaluate the percentage of hyperlipidemia patients who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007) following 8-week treatment by Crestor® 5mg or 10mg
Conditions
Timeline
- Start date
- 2008-10-01
- Completion
- 2009-07-01
- First posted
- 2008-10-29
- Last updated
- 2009-08-07
Locations
15 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00781560. Inclusion in this directory is not an endorsement.